Angst bei der Nachsorge: Prostata.

A recent US study details what men with prostate cancer worry about the most

A recent US study based upon an online survey of patients and their caregivers asked the question, “What is it like to live with prostate cancer?” A total of 925 men with prostate cancer, and 25 caregivers took part in the survey . The results of the study detail the “pervasive and overwhelming” effects that prostate cancer has on a patients’ quality of life and daily routines.

What do men with prostate cancer find most frustrating?

According to the survey, from the time of diagnosis to treatment – patients continually fear that their disease will progress or even relapse after a treatment. Prostate Cancer patients also felt a lack of motivation, and had problems in their sex life, often accompanied by depression and sorrow. The side effects of conventional therapies for malignant prostate disorders have a considerable impact on the sex life and bladder function of patients, and significantly limit their quality of life.

In response to the question “What frustrates you the most?, the study participants most often mentioned “sexual dysfunction”, followed by bladder and intestinal problems, anxiety about the future and the impression that they “no longer felt like a real man”.

During follow-up care, there is a lasting fear that their prostate cancer could return

Of the people surveyed, 71 percent had follow-up examinations and diagnostic imaging performed at least twice a year. Follow-up care is important to detect a relapse of the disorder at an early stage. However, follow-ups can cause men to think often about whether their cancer will return. This has an emotional effect that should not be underestimated. Fear of recurrence affects patients drastically; this is observed by analysing the language patients use to describe prostate cancer: terms like “hell”, “terrifying”, “destructive” and “terrible” were mentioned most often. In contrast, terms like “treatable” and “manageable” were used less common.